SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347613-17-000005
Filing Date
2017-08-09
Accepted
2017-08-09 16:56:59
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-63017x10q.htm 10-Q 605656
2 EXHIBIT 31.1 sgyp-ex311x63017x10q.htm EX-31.1 11930
3 EXHIBIT 31.2 sgyp-ex312x6x30x17x10q.htm EX-31.2 11971
4 EXHIBIT 32.1 sgyp-ex321x6x30x17x10q.htm EX-32.1 6817
5 EXHIBIT 32.2 sgyp-ex322x6x30x17x10q.htm EX-32.2 7535
  Complete submission text file 0001347613-17-000005.txt   3639698

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20170630.xml EX-101.INS 626670
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20170630.xsd EX-101.SCH 29754
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20170630_cal.xml EX-101.CAL 45558
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20170630_def.xml EX-101.DEF 163964
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20170630_lab.xml EX-101.LAB 434112
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20170630_pre.xml EX-101.PRE 268577
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 171018661
SIC: 2834 Pharmaceutical Preparations